| Enterprise Optical Llc | |
|
812 E. Lee, Enterprise, AL 36330 | |
| (334) 393-2020 | |
| (334) 393-6936 |
| Full Name | Enterprise Optical Llc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 812 E. Lee, Enterprise, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538179866 | NPI | - | NPPES |
| 111905 | Other | AL | EYEMED |
| 51004506 | Other | AL | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Enterprise Optical Llc 812 E. Lee, Enterprise, AL 36330 Ph: (334) 393-2020 | Enterprise Optical Llc 812 E. Lee, Enterprise, AL 36330 Ph: (334) 393-2020 |
News Archive
"Managing and Securing Mobile Healthcare Data and Devices," a commissioned technology adoption profile conducted by Forrester Consulting on behalf of Fiberlink Communications Corporation was released today with findings on the top needs of healthcare IT leaders. With 95% of healthcare enterprises relying on smartphones for work, this industry is one of the most mobile across all verticals.
New Jersey would lose over 2,400 jobs, local economies would suffer and patients may be denied their choice of pharmacy if the proposed mega-merger of two prescription drug middlemen goes through, the National Community Pharmacists Association (NCPA) said today.
The combination of a cholesterol-lowering drug, Bezafibrate, and a contraceptive steroid, Medroxyprogesterone Acetate, could be an effective, non-toxic treatment for a range of cancers, researchers at the University of Birmingham have found.
MAP Pharmaceuticals, Inc. today reported successful results from a thorough QT trial of its investigational LEVADEX™ orally inhaled migraine therapy. The trial evaluated the potential of a supra-therapeutic dose to cause an increase in the QT interval. Results of the trial showed that a supra-therapeutic dose of LEVADEX does not increase QTc intervals. LEVADEX is a novel orally inhaled migraine therapy that has completed Phase 3 efficacy development for the acute treatment of migraine.
The importance of bending the cost curve for Ontario's health care sector has long been top of mind for health system leaders. After all, improving the quality and efficiency of patient care can lead to better value-for-money for taxpayers.
› Verified 2 days ago
Eye Care Associates, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 820 East Lee Street, Enterprise, AL 36330 Phone: 334-393-2020 Fax: 636-527-0766 | |
Dr. Douglas W Devore, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 820 E Lee St, Enterprise, AL 36330 Phone: 334-393-2020 | |
Lorie C Woods, OD Optometrist Medicare: Medicare Enrolled Practice Location: 812 E Lee St, Enterprise, AL 36330 Phone: 334-393-2020 Fax: 334-393-6936 | |
Bender Eyecare Optometrist Medicare: Medicare Enrolled Practice Location: 1020 B Boll Weevil Circle, Enterprise, AL 36330 Phone: 334-347-2732 Fax: 334-347-2732 | |
Dr. Brian Edward Kurtz, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 820 E Lee St, Enterprise, AL 36330 Phone: 334-393-2020 | |
Dr. Gary Dale Dobbs, Optometrist Medicare: Medicare Enrolled Practice Location: 207 S Main St, Enterprise, AL 36330 Phone: 334-347-8900 Fax: 334-347-1480 | |
Dr. Velvet Jeter Maddox, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 607-c Boll Weevil Circle, Enterprise, AL 36330 Phone: 334-347-6599 Fax: 334-347-6599 |